(Q34214436)

31 July 2017

1 reference

title

Angiogenesis as a potential biomarker in prostate cancer chemoprevention trials (English)

1 reference

31 July 2017

0 references

1 reference

Ali IU

1

1 reference

31 July 2017

Senger DR

series ordinal

2

1 reference

31 July 2017

Smith LE

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

31 July 2017

1 reference

31 July 2017

57

1 reference

31 July 2017

4 Suppl 1

1 reference

31 July 2017

143-147

1 reference

Early detection of prostate cancer

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Molecular biology of progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Molecular advances in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Molecular biology of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Tumour suppressor genes in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Comparison of ras activation in prostate carcinoma in Japanese and American men

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Platelet-derived growth factor A and B chains and the alpha and beta receptors in prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Prognostic value of immunohistochemical expression of the c-erbB-2 oncoprotein in metastasic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Oncogenes in prostate cancer. An update

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Oncogenes and tumor suppressor genes in prostate cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Epigenetic mechanisms for progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

1 reference

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Advances in angiogenesis research: relevance to urological oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Quantitative microvessel density. A staging and prognostic marker for human prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Immunohistochemical determination of tumor angiogenesis measured by the maximal microvessel density in human prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

The antiangiogenic agent linomide inhibits tumor necrosis factor-alpha secretion via inhibition of its synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Tumor angiogenesis: the pivotal role of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Expression of vascular endothelial growth factor receptors in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Towards fully automated genome-wide polymorphism screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Real time quantitative PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

The role of vascular endothelial growth factor in pathological angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

Clinical evidence for and implications of the multistep development of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900961-4

7 January 2021

10.1016/S0090-4295(00)00961-4

Identifiers

DOI

1 reference

31 July 2017

1 reference